Vicus Capital Buys 53,518 Shares of Colgate-Palmolive Company (CL)
Vicus Capital increased its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 79.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 120,867 shares of the company’s stock after buying an additional 53,518 shares during the period. Colgate-Palmolive comprises 1.8% of Vicus Capital’s investment portfolio, making the stock its 11th largest position. Vicus Capital’s holdings in Colgate-Palmolive were worth $8,960,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in CL. Chickasaw Capital Management LLC boosted its position in shares of Colgate-Palmolive by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock valued at $1,238,000 after buying an additional 11,605 shares during the period. Meritage Portfolio Management boosted its position in shares of Colgate-Palmolive by 0.3% in the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock valued at $7,017,000 after buying an additional 255 shares during the period. Eastern Bank boosted its position in shares of Colgate-Palmolive by 0.8% in the first quarter. Eastern Bank now owns 10,939 shares of the company’s stock valued at $801,000 after buying an additional 89 shares during the period. ProShare Advisors LLC boosted its position in shares of Colgate-Palmolive by 9.9% in the first quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock valued at $64,382,000 after buying an additional 79,323 shares during the period. Finally, Geneva Advisors LLC boosted its position in shares of Colgate-Palmolive by 2.5% in the first quarter. Geneva Advisors LLC now owns 18,051 shares of the company’s stock valued at $1,321,000 after buying an additional 438 shares during the period. Institutional investors own 73.69% of the company’s stock.
Shares of Colgate-Palmolive Company (NYSE CL) traded down 0.21% during midday trading on Thursday, hitting $71.78. 1,472,881 shares of the stock were exchanged. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The company has a market cap of $63.23 billion, a PE ratio of 26.67 and a beta of 0.80. The stock has a 50 day moving average price of $72.49 and a 200-day moving average price of $72.87. Colgate-Palmolive also was the target of some unusual options trading activity on Tuesday. Stock investors acquired 12,928 put options on the stock. This is an increase of approximately 560% compared to the average volume of 1,959 put options.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. The firm had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The business’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter last year, the business earned $0.70 earnings per share. On average, analysts predict that Colgate-Palmolive Company will post $2.89 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/17/vicus-capital-buys-53518-shares-of-colgate-palmolive-company-cl.html.
Several equities analysts recently commented on CL shares. Bank of America Corporation boosted their target price on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Vetr cut Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research report on Wednesday, May 17th. Royal Bank Of Canada restated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research report on Thursday, May 25th. Finally, Jefferies Group LLC restated a “hold” rating and set a $76.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, May 17th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $75.82.
In other news, SVP John J. Huston sold 14,000 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $71.36, for a total transaction of $999,040.00. Following the completion of the sale, the senior vice president now directly owns 88,598 shares in the company, valued at $6,322,353.28. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Dennis J. Hickey sold 73,872 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total transaction of $5,304,009.60. Following the sale, the chief financial officer now owns 484,985 shares of the company’s stock, valued at $34,821,923. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 217,969 shares of company stock valued at $15,710,108. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.